86 related articles for article (PubMed ID: 8882317)
1. T cell-mediated destruction of bovine leukemia virus-infected peripheral lymphocytes by bovine leukemia virus env-vaccinia recombinant vaccine.
Ohishi K; Ikawa Y
AIDS Res Hum Retroviruses; 1996 Mar; 12(5):393-8. PubMed ID: 8882317
[No Abstract] [Full Text] [Related]
2. Role of cell-mediated immunity in bovine leukemia virus (BLV) infection in ruminants: its implication for the vaccination strategy against retroviruses.
Sugimoto M; Ohishi K; Ikawa Y
Ther Immunol; 1994 Oct; 1(5):297-301. PubMed ID: 7584504
[TBL] [Abstract][Full Text] [Related]
3. Protective immunity against bovine leukaemia virus (BLV) induced in carrier sheep by inoculation with a vaccinia virus-BLV env recombinant: association with cell-mediated immunity.
Ohishi K; Suzuki H; Yamamoto T; Maruyama T; Miki K; Ikawa Y; Numakunai S; Okada K; Ohshima K; Sugimoto M
J Gen Virol; 1991 Aug; 72 ( Pt 8)():1887-92. PubMed ID: 1651982
[TBL] [Abstract][Full Text] [Related]
4. Protection of sheep against bovine leukemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: correlation of protection with CD4 T-cell response to gp51 peptide 51-70.
Gatei MH; Naif HM; Kumar S; Boyle DB; Daniel RC; Good MF; Lavin MF
J Virol; 1993 Apr; 67(4):1803-10. PubMed ID: 7680387
[TBL] [Abstract][Full Text] [Related]
5. Viral status and antibody response in cattle inoculated with recombinant bovine leukemia virus-vaccinia virus vaccines after challenge exposure with bovine leukemia virus-infected lymphocytes.
Cherney TM; Schultz RD
Am J Vet Res; 1996 Jun; 57(6):812-8. PubMed ID: 8725805
[TBL] [Abstract][Full Text] [Related]
6. Vaccination of cattle with binary ethylenimine-treated bovine leukemia virus.
Miller JM; Van der Maaten MJ; Schmerr MJ
Am J Vet Res; 1983 Jan; 44(1):64-7. PubMed ID: 6297341
[No Abstract] [Full Text] [Related]
7. [Protection of sheep against infection with bovine leukemia virus by vaccination with tumor cells or tumor cell preparations from lymph nodes of leukemic cattle].
Ristau E; Beier D; Wittmann W; Klima F
Arch Exp Veterinarmed; 1987 Mar; 41(2):185-96. PubMed ID: 3038049
[No Abstract] [Full Text] [Related]
8. Evaluation of an inactivated bovine leukemia virus preparation as an immunogen in cattle.
Miller JM; Van Der Maaten MJ
Ann Rech Vet; 1978; 9(4):871-7. PubMed ID: 224789
[No Abstract] [Full Text] [Related]
9. The possibility of specific protection against bovine leukaemia virus infection and bovine leukaemia with inactivated BLV.
Parfanovich MI; Zhdanov VM; Lazarenko AA; Nömm EM; Simovart YuA ; Parakin VK; Lemesh VM
Br Vet J; 1983; 139(2):137-46. PubMed ID: 6301618
[No Abstract] [Full Text] [Related]
10. Specific protection against bovine leukemia virus infection conferred on cattle by the Romanian inactivated vaccine BL-VACC-RO.
Pătraşcu IV; Coman S; Sandu I; Stiube P; Munteanu I; Coman T; Ionescu M; Popescu D; Mihăilescu D
Virologie; 1980; 31(2):95-102. PubMed ID: 6250281
[TBL] [Abstract][Full Text] [Related]
11. Antibody to bovine leukemia virus in sera from leukemic patients.
Cereda PM; Debiaggi M; Romero E
Microbiologica; 1984 Jan; 7(1):107-12. PubMed ID: 6328223
[TBL] [Abstract][Full Text] [Related]
12. Involvement of CD8+ T cells in delayed-type hypersensitivity responses against bovine leukemia virus (BLV) induced in sheep vaccinated with recombinant vaccinia virus expressing BLV envelope glycoprotein.
Okada K; Ikeyama S; Ohishi K; Suzuki H; Sugimoto M; Numakunai S; Chiba T; Murakami K; Davis WC; Ohshima K
Vet Pathol; 1993 Mar; 30(2):104-10. PubMed ID: 8470333
[TBL] [Abstract][Full Text] [Related]
13. Cell-mediated immunity to BLV replication: analogous to HIV immunopathogenesis?
Sugimoto M; Ohishi K; Ikawa Y
Immunol Today; 1993 Apr; 14(4):190-1. PubMed ID: 8388695
[No Abstract] [Full Text] [Related]
14. [Effect of vaccination against foot-and-mouth disease on results of the immunodiffusion test for the demonstration of precipitating bovine leukosis virus antibodies].
Straub OC
Dtsch Tierarztl Wochenschr; 1983 Apr; 90(4):135-7. PubMed ID: 6305624
[No Abstract] [Full Text] [Related]
15. Bovine leukemia virus, a versatile agent with various pathogenic effects in various animal species.
Burny A; Bruck C; Cleuter Y; Couez D; Deschamps J; Ghysdael J; Grégoire D; Kettmann R; Mammerickx M; Marbaix G
Cancer Res; 1985 Sep; 45(9 Suppl):4578s-4582s. PubMed ID: 2410107
[TBL] [Abstract][Full Text] [Related]
16. Delayed emergence of bovine leukemia virus after vaccination with a protective cytotoxic T cell-based vaccine.
Mateo L; Gardner J; Suhrbier A
AIDS Res Hum Retroviruses; 2001 Oct; 17(15):1447-53. PubMed ID: 11679157
[TBL] [Abstract][Full Text] [Related]
17. Cell-derived vaccine against bovine leukaemia virus infection.
Altaner C; Altanerova V; Ban J; Janik V; Volejnicek V; Frajs Z; Cerny L
Zentralbl Veterinarmed B; 1988 Dec; 35(10):736-46. PubMed ID: 2851239
[No Abstract] [Full Text] [Related]
18. Humoral antibody response to bovine leukemia virus infection in cattle and sheep.
Bex F; Bruck C; Mammerickx M; Portetelle D; Ghysdael J; Cleuter Y; Leclercq M; Dekegel D; Burny A
Cancer Res; 1979 Mar; 39(3):1118-23. PubMed ID: 218722
[TBL] [Abstract][Full Text] [Related]
19. Protection of cattle against bovine leukemia virus (BLV) infection could be attained by DNA vaccination.
Brillowska A; Dabrowski S; Rułka J; Kubiś P; Buzała E; Kur J
Acta Biochim Pol; 1999; 46(4):971-6. PubMed ID: 10824867
[TBL] [Abstract][Full Text] [Related]
20. Peptide-based bovine leukemia virus (BLV) vaccine that induces BLV-Env specific Th-1 type immunity.
Ohishi K; Kabeya H; Amanuma H; Onuma M
Leukemia; 1997 Apr; 11 Suppl 3():223-6. PubMed ID: 9209348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
